IL-13 Antikörper (Interleukin 13) (AA 35-146)

Details for Product anti-IL13 Antibody No. ABIN4900267, Anbieter: Anmelden zum Anzeigen
Antigen
  • IL13
  • IL-13
  • P600
  • Il-13
  • L13
  • interleukin 13
  • interleukin-13
  • IL13
  • Il13
  • IL-13
Epitop
AA 35-146
24
16
15
12
8
6
5
4
3
3
3
2
2
2
2
2
1
1
1
1
Reaktivität
Human
247
81
53
10
9
5
3
2
1
1
1
Wirt
Maus
160
129
70
5
3
Klonalität (Klon)
Monoklonal ()
Konjugat
Dieser IL-13 Antikörper ist unkonjugiert
39
14
13
8
8
7
7
6
6
5
5
5
4
4
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
Applikation
Cytometry by Time of Flight (CyTOF), Flow Cytometry (FACS), Neutralization (Neut), Western Blotting (WB)
206
204
103
54
42
28
23
13
12
12
11
10
7
5
4
4
4
3
3
2
2
1
1
1
1
1
1
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Immunogen E. coli-derived recombinant human IL-13, Gly35-Asn146, Accession # P35225
Klon 31606
Isotyp IgG1
Spezifität Detects human IL-13 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human IL-4 or recombinant mouse IL-13 is observed.
Reinigung Protein A or G purified from ascites
Sterilität 0.2 μm filtered
Endotoxin-Niveau <0.10 EU per 1 μg of the antibody by the LAL method.
Andere Bezeichnung IL-13 (IL13 Antibody Abstract)
Hintergrund Alternative Names: ALRHMGC116789, BHR1interleukin-13, IL13, IL-13MGC116788, interleukin 13, MGC116786, NC30, P600
Gen-ID 3596
UniProt P35225
Forschungsgebiet Cytokines, Innate Immunity, Cancer
Pathways JAK-STAT Signalweg, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Proton Transport
Applikationshinweise Western Blot 1 μg/mL
Flow Cytometry 2.5 μg/10^6 cells
Neutralization 1-4 μg/mL
CyTOF-ready
Beschränkungen Nur für Forschungszwecke einsetzbar
Rekonstitution Reconstitute at 0.5 mg/mL in sterile PBS.
Buffer Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Konservierungsmittel Without preservative
Lagerung 4 °C,-20 °C,-80 °C
Informationen zur Lagerung Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt,-20°C to -70°C as supplied. 1 month,2°C to 8°C under sterile conditions after reconstitution. 6 months,-20°C to -70°C under sterile conditions after reconstitution.
Haltbarkeit 12 months
Bilder des Herstellers
Neutralization (Neut) image for anti-Interleukin 13 (IL13) (AA 35-146) antibody (ABIN4900267) Cell Proliferation Induced by IL-13 and Neutralization by Human IL-13 Antibody. Recom...
Flow Cytometry (FACS) image for anti-Interleukin 13 (IL13) (AA 35-146) antibody (ABIN4900267) Detection of IL-13 in Human PBMCs by Flow Cytometry. Human peripheral blood mononucle...
Neutralization (Neut) image for anti-Interleukin 13 (IL13) (AA 35-146) antibody (ABIN4900267) Cell Proliferation Induced by IL-13 and Neutralization by Human IL-13 Antibody. Recom...
Flow Cytometry (FACS) image for anti-Interleukin 13 (IL13) (AA 35-146) antibody (ABIN4900267) Detection of IL-13 in Human PBMCs by Flow Cytometry. Human peripheral blood mononucle...
Produkt verwendet in: van Meijgaarden, Haks, Caccamo, Dieli, Ottenhoff, Joosten et al.: "Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human ..." in: PLoS pathogens, Vol. 11, Issue 3, pp. e1004671, 2015 (PubMed). Von den Autoren verwendete Methode: Blocking Peptide (BP) (Probematerial (Species): Human).

Haas, Amin, Ruth, Allen, Ahmed, Pakozdi, Woods, Shahrara, Koch: "In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis." in: Arthritis and rheumatism, Vol. 56, Issue 8, pp. 2535-48, 2007 (PubMed). Von den Autoren verwendete Methode: Neutralization (Neut) (Probematerial (Species): Rat (Rattus)).

Haben Sie etwas anderes gesucht?